391 related articles for article (PubMed ID: 15946719)
21. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
Welfringer F; d'Athis P; Scherrmann JM; Hervé F
J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
[TBL] [Abstract][Full Text] [Related]
22. Subacute coagulopathy in a randomized, comparative trial of Fab and F(ab')2 antivenoms.
Boyer LV; Chase PB; Degan JA; Figge G; Buelna-Romero A; Luchetti C; Alagón A
Toxicon; 2013 Nov; 74():101-8. PubMed ID: 23948058
[TBL] [Abstract][Full Text] [Related]
23. Comparison between IgG and F(ab')(2) polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions.
León G; Monge M; Rojas E; Lomonte B; Gutiérrez JM
Toxicon; 2001 Jun; 39(6):793-801. PubMed ID: 11137538
[TBL] [Abstract][Full Text] [Related]
24. Serum level of scorpion toxins, electrolytes and electrocardiogram alterations in Mexican children envenomed by scorpion sting.
Osnaya-Romero N; Acosta-Saavedra LC; Goytia-Acevedo R; Lares-Asseff I; Basurto-Celaya G; Perez-Guille G; Possani LD; Calderón-Aranda ES
Toxicon; 2016 Nov; 122():103-108. PubMed ID: 27693586
[TBL] [Abstract][Full Text] [Related]
25. [Recombinant antibodies: a new application in scorpion envenomation?].
Muzard J; Billiald P; Goyffon M; Aubrey N
Bull Soc Pathol Exot; 2005 Dec; 98(5):383-5. PubMed ID: 16425719
[TBL] [Abstract][Full Text] [Related]
26. Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
Tahtis K; Lee FT; Smyth FE; Power BE; Renner C; Brechbiel MW; Old LJ; Hudson PJ; Scott AM
Clin Cancer Res; 2001 Apr; 7(4):1061-72. PubMed ID: 11309358
[TBL] [Abstract][Full Text] [Related]
27. [Inhibition of thrombocyte aggregation by F(ab')2-fragments of monoclonal antibodies FraMon (CRC64) to glycoproteins IIb-IIIa].
Mazurov AV; Pevzner DV; Khaspekova SG; Dudnik OA; Byzova TV; Vlasik TN; Bakharev VN; Pistsov MIu; Staroverov II; Ruda MIa
Ter Arkh; 2001; 73(9):66-73. PubMed ID: 11642086
[TBL] [Abstract][Full Text] [Related]
28. Development of an improved method for production of antiscorpion F(ab')2 fragment of IgG with high yield and potency.
Seddik SS; Wanas S; Shehata A; Fawaz S; Helmy MH
J Nat Toxins; 2002 May; 11(2):123-32. PubMed ID: 12009112
[TBL] [Abstract][Full Text] [Related]
29. Preparation of F(ab')
Ismael BN; Abass KS; Khalil KA; Salih KA
Biologicals; 2018 Nov; 56():19-23. PubMed ID: 30153952
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of a F(ab')2 scorpion antivenom in healthy human volunteers.
Vázquez H; Chávez-Haro A; García-Ubbelohde W; Mancilla-Nava R; Paniagua-Solís J; Alagón A; Sevcik C
Toxicon; 2005 Dec; 46(7):797-805. PubMed ID: 16197974
[TBL] [Abstract][Full Text] [Related]
31. [Application of ELISA for the quantification of Androctonus australis hector venom in the envenomed serum of people and rats before and after immunotherapy].
Hammoudi-Triki D; Laraba-Djebari F
Bull Soc Pathol Exot; 2003 Nov; 96(4):297-301. PubMed ID: 14717046
[TBL] [Abstract][Full Text] [Related]
32. The dynamics of cytokine d nitric oxide secretion in mice injected with Tityus serrulatus scorpion venom.
Petricevich VL; Peña CF
Mediators Inflamm; 2002 Jun; 11(3):173-80. PubMed ID: 12137246
[TBL] [Abstract][Full Text] [Related]
33. Comparative study on the ability of IgG and F(ab')2 antivenoms to neutralize lethal and myotoxic effects induced by Micrurus nigrocinctus (coral snake) venom.
León G; Stiles B; Alape A; Rojas G; Gutiérrez JM
Am J Trop Med Hyg; 1999 Aug; 61(2):266-71. PubMed ID: 10463678
[TBL] [Abstract][Full Text] [Related]
34. General biochemical and immunological characterization of the venom from the scorpion Tityus trivittatus of Argentina.
de Roodt AR; Coronas FI; Lago N; González ME; Laskowicz RD; Beltramino JC; Saavedra S; López RA; Reati GJ; Vucharchuk MG; Bazán E; Varni L; Salomón OD; Possani LD
Toxicon; 2010; 55(2-3):307-19. PubMed ID: 19706301
[TBL] [Abstract][Full Text] [Related]
35. Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.
Lu J; Guo Z; Pan X; Wang G; Zhang D; Li Y; Tan B; Ouyang L; Yu X
Respir Res; 2006 Mar; 7(1):43. PubMed ID: 16553963
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of a F(ab')2 scorpion antivenom administered intramuscularly in healthy human volunteers.
Vázquez H; Chávez-Haro A; García-Ubbelohde W; Paniagua-Solís J; Alagón A; Sevcik C
Int Immunopharmacol; 2010 Nov; 10(11):1318-24. PubMed ID: 20849955
[TBL] [Abstract][Full Text] [Related]
37. [Effects of immunoglobulin on murine myocarditis caused by influenza A virus: experimental study].
Kishimoto C; Hiraoka Y; Takada H; Kurokawa M; Ochiai H
J Cardiol; 2005 Jun; 45(6):247-55. PubMed ID: 15991608
[TBL] [Abstract][Full Text] [Related]
38. Production of anti-horse antibodies induced by IgG, F(ab')2 and Fab applied repeatedly to rabbits. Effect on antivenom pharmacokinetics.
Vázquez H; Olvera F; Alagón A; Sevcik C
Toxicon; 2013 Dec; 76():362-9. PubMed ID: 24047962
[TBL] [Abstract][Full Text] [Related]
39. Fractionated radioimmunotherapy of intraperitoneally growing ovarian cancer in nude mice with 211At-MX35 F(ab')2: therapeutic efficacy and myelotoxicity.
Elgqvist J; Andersson H; Bäck T; Claesson I; Hultborn R; Jensen H; Lindegren S; Olsson M; Palm S; Warnhammar E; Jacobsson L
Nucl Med Biol; 2006 Nov; 33(8):1065-72. PubMed ID: 17127181
[TBL] [Abstract][Full Text] [Related]
40. Human F(ab')2-containing immune complexes together with anti-hinge natural antibodies stimulate complement amplification in vitro and in vivo.
Fumia S; Goede JS; Fischler M; Luginbühl A; Frick S; Fodor P; Lutz HU
Mol Immunol; 2008 May; 45(10):2951-61. PubMed ID: 18339427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
